Researchers have demonstrated that small molecules mimicking activated protein C could provide anti-inflammatory and anti-thrombotic protection without interfering with blood clotting, becoming attractive drug candidates.
A research team from Brazil has combined two techniques to identify over 10, 000 proteins expressed in oligodendrocytes in an effort to better understand the causes of schizophrenia.
Bioanalysis Zone and Bioanalysis welcome unsolicited submissions to both the journal and website!
Wacker Biotech GmbH (Jena, Germany) have announced that they will manufacture the active ingredient in the drug Retavase®. This drug has obtained FDA approval to treat acute myocardial infarction in adults.
Bioanalysis Zone today announced the winner of the Bioanalysis Outstanding Contribution Award – BOSCA – awarded to bioanalytical scientists for outstanding work and contribution to the community.
Issue 2 of Bioanalysis volume 10 is now available, including an editorial discussing exhaled breath condensate as an alternative sample for drug monitoring, a commentary on immunogenicity considerations for antibody–drug conjugates and a special report on the current considerations for anti-drug antibody assay in Japan.
From novel analytical instrumentation to the recent developments in the bioanalysis of biopharmaceuticals and biomarkers, as the New Year starts we’re looking back on the bioanalytical highlights from 2017.
Bioanalysis volume 10 issue 1 is now available, including three research articles on novel immunocapture enrichment with LC–MS/MS, a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis and the detection of biomarkers by high-throughput suspension array technology.
Take a look at our overview of the top events in the world of bioanalysis for January, February and March 2018
Find out what we have coming up in the New Year.